{"transactions":[{"id":1436058,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-12T20:33:19.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":387999,"price":1.1005,"value":426992.8995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.10 to $1.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP, L.P. (\"VV VI GP\") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC (\"VV VI GP-GP\") is the general partner of VV VI GP and each may be deemed to share voting, investment and dispositive power over the shares held by VVC VI. Each of VV VI GP-GP and VV VI GP disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":209941,"source":{"system":"sec-edgar","filing":"0000950170-24-095675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777652/000095017024095675/ownership.xml","form_type":"4"}},{"id":1436057,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74646,"kind":"organization","name":"Versant Vantage II, L.P.","position":4,"cik":"0001832235","reported_name":"Versant Vantage II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74647,"kind":"organization","name":"Versant Vantage II GP, L.P.","position":5,"cik":"0001839790","reported_name":"Versant Vantage II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74648,"kind":"organization","name":"Versant Vantage II GP-GP, LLC","position":6,"cik":"0001839789","reported_name":"Versant Vantage II GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-12T20:33:19.000Z","date":"2024-08-08","kind":"sale","planned":false,"acquired":false,"shares":400000,"price":1.3501,"value":540040.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.35 to $1.375, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP, L.P. (\"VV VI GP\") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC (\"VV VI GP-GP\") is the general partner of VV VI GP and each may be deemed to share voting, investment and dispositive power over the shares held by VVC VI. Each of VV VI GP-GP and VV VI GP disclaim beneficial ownership of such shares, except to the extent of their respective pecuniary interests therein."}],"balance_after":597940,"source":{"system":"sec-edgar","filing":"0000950170-24-095675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777652/000095017024095675/ownership.xml","form_type":"4"}},{"id":1543220,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":275769,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP, L.P. (\"VV I GP\") is the general partner of VV I, and Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein."}],"balance_after":710494,"derivative":{"underlying":"Class B Common Stock","underlying_shares":275769},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543219,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":689,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":12123,"derivative":{"underlying":"Class B Common Stock","underlying_shares":689},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543218,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":110187,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":1934776,"derivative":{"underlying":"Class B Common Stock","underlying_shares":110187},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543217,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":317988,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The shares are held directly by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP, L.P. (\"VV VI GP\") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC (\"VV VI GP-GP\") is the general partner of VV VI GP. Each of VV VI GP-GP and VV VI GP disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein."}],"balance_after":1741107,"derivative":{"underlying":"Class B Common Stock","underlying_shares":317988},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543216,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":434725,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP, L.P. (\"VV I GP\") is the general partner of VV I, and Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein."}],"balance_after":434725,"derivative":{"underlying":"Class B Common Stock","underlying_shares":434725},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543215,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":2182,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":11434,"derivative":{"underlying":"Class B Common Stock","underlying_shares":2182},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543214,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":348143,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":1824589,"derivative":{"underlying":"Class B Common Stock","underlying_shares":348143},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543213,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":1423119,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"The shares are held directly by Versant Venture Capital VI, L.P. (\"VVC VI\"). Versant Ventures VI GP, L.P. (\"VV VI GP\") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC (\"VV VI GP-GP\") is the general partner of VV VI GP. Each of VV VI GP-GP and VV VI GP disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein."}],"balance_after":1423119,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1423119},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543212,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":9252,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":9252,"derivative":{"underlying":"Class B Common Stock","underlying_shares":9252},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543211,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":1476446,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with the closing of the IPO, the Reporting Persons elected to have such shares of Preferred Stock convert into shares of the Issuer's Class B common stock (the \"Class B Common Stock\"), on a one-for-one basis for no additional consideration.  The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each share of the Issuer's Class B Common Stock is convertible into one share of Class A Common Stock at the holder's election, provided that as a result of such conversion, such holder, together with its affiliates, will not beneficially own in excess of 4.99% of the Issuer's Class A Common Stock immediately prior to and following such conversion. However, this ownership limitation may be increased or decreased to any other percentage designated by such holder of Class B Common Stock upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":1476446,"derivative":{"underlying":"Class B Common Stock","underlying_shares":1476446},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543210,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":57565,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP, L.P. (\"VV I GP\") is the general partner of VV I, and Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":57565},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543209,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":145,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":145},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543208,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":22312,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":22312},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543207,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":90747,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP, L.P. (\"VV I GP\") is the general partner of VV I, and Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":90747},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543206,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":455,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":455},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543205,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":70498,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":70498},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543204,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":1931,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1931},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543203,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":298975,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":298975},"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543202,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":148312,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held directly by Versant Vantage I, L.P. (\"VV I\"). Versant Vantage I GP, L.P. (\"VV I GP\") is the general partner of VV I, and Versant Vantage I GP-GP, LLC (\"VV I GP-GP\") is the general partner of VV I GP. Each of VV I GP-GP and VV I GP disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein."}],"balance_after":148312,"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543201,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":2531,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held directly by Versant Side Fund IV, L.P. (\"VSF IV\"). VV IV GP is the general partner of VSF IV and disclaims beneficial ownership of the shares held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":2531,"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":1543200,"issuer":{"id":5311,"kind":"organization","name":"Contineum Therapeutics, Inc.","symbol":"CTNM"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":7,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":8,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":9,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-04-11T22:10:57.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":391785,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering (the \"IPO\"), such shares of the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock (collectively, the \"Preferred Stock\") converted automatically into shares of the Issuer's Class A common stock (the \"Class A Common Stock\"), on a one-for-one basis for no additional consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by Versant Venture Capital IV, L.P. (\"VVC IV\"). Versant Ventures IV, LLC (\"VV IV GP\") is the general partner of VVC IV and disclaims beneficial ownership of the shares held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":391785,"source":{"system":"sec-edgar","filing":"0000899243-24-000269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855175/000089924324000269/doc4.xml","form_type":"4"}},{"id":2068178,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T18:11:53.000Z","date":"2023-01-03","kind":"other","acquired":false,"shares":1003658,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. (\"Purchaser\"), a wholly owned subsidiary of Viatris, Inc. (\"Viatris\"), and Viatris, Purchaser commenced a tender offer (the \"Offer\") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the \"Merger\"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the \"Effective Time\")(continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the \"Milestone Payment\" and together with the Cash Amount, the \"Per Share Price\") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage\"). Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the sole general partner of Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") and Versant Vantage I GP is the sole general Partner of Versant Vantage. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage. Each of Versant Vantage I GP-GP, Versant Vantage I GP, and Clare Ozawa disclaims beneficial ownership of the shares held by Versant Vantage, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924323000677/doc4.xml","form_type":"4"}},{"id":2068177,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T18:11:53.000Z","date":"2023-01-03","kind":"other","acquired":false,"shares":2465,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. (\"Purchaser\"), a wholly owned subsidiary of Viatris, Inc. (\"Viatris\"), and Viatris, Purchaser commenced a tender offer (the \"Offer\") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the \"Merger\"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the \"Effective Time\")(continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the \"Milestone Payment\" and together with the Cash Amount, the \"Per Share Price\") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\"). Versant Ventures IV is the sole general partner of Versant Side Fund IV. Versant Ventures IV disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of its pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924323000677/doc4.xml","form_type":"4"}},{"id":2068176,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T18:11:53.000Z","date":"2023-01-03","kind":"other","acquired":false,"shares":414607,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. (\"Purchaser\"), a wholly owned subsidiary of Viatris, Inc. (\"Viatris\"), and Viatris, Purchaser commenced a tender offer (the \"Offer\") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the \"Merger\"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the \"Effective Time\")(continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the \"Milestone Payment\" and together with the Cash Amount, the \"Per Share Price\") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Venture Capital IV, L.P. (\"Versant IV\"). Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. Versant Ventures IV disclaims beneficial ownership of the shares held by Versant IV, except to the extent of its pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924323000677/doc4.xml","form_type":"4"}},{"id":2068175,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T18:11:53.000Z","date":"2023-01-03","kind":"other","acquired":false,"shares":2236888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 7, 2022, among the Issuer, Iris Purchaser Inc. (\"Purchaser\"), a wholly owned subsidiary of Viatris, Inc. (\"Viatris\"), and Viatris, Purchaser commenced a tender offer (the \"Offer\") to purchase all the outstanding common stock of the Issuer for the Per Share Price (as defined below). On January 3, 2023, the Offer consummated, after which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Viatris (the \"Merger\"). At the consummation of the Offer and the Merger, respectively, (i) Purchaser purchased all shares of Issuer's common stock that were validly tendered pursuant to the Offer for a cash payment equal to the Per Share Price and (ii) each share of the Issuer's common stock that was issued and outstanding immediately prior to the effective time of the Merger (the \"Effective Time\")(continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(other than shares that were held (a) by the Issuer (including any treasury shares) or by Viatris or Purchaser or any other direct or indirect wholly owned subsidiary of Viatris or (b) by stockholders of the Issuer who had properly exercised and perfected, and not withdrawn or otherwise lost, their appraisal rights under the Delaware General Corporate Law) was cancelled and converted into the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved (the \"Milestone Payment\" and together with the Cash Amount, the \"Per Share Price\") pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Shares held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") and Versant Ventures VI GP is the sole general partner of Versant VI. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP and Clare Ozawa disclaims beneficial ownership of the shares held by Versant VI, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924323000677/doc4.xml","form_type":"4"}},{"id":2440200,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T16:20:37.000Z","date":"2022-01-05","kind":"other","acquired":false,"shares":1261,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":2465,"source":{"system":"sec-edgar","filing":"0000899243-22-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924322001360/doc4.xml","form_type":"4"}},{"id":2440199,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T16:20:37.000Z","date":"2022-01-05","kind":"other","acquired":false,"shares":51556,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924322001360/doc4.xml","form_type":"4"}},{"id":2440198,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T16:20:37.000Z","date":"2022-01-05","kind":"other","acquired":true,"shares":51556,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":51556,"source":{"system":"sec-edgar","filing":"0000899243-22-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924322001360/doc4.xml","form_type":"4"}},{"id":2440197,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T16:20:37.000Z","date":"2022-01-05","kind":"other","acquired":false,"shares":200213,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. (\"Versant IV\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":414607,"source":{"system":"sec-edgar","filing":"0000899243-22-001360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924322001360/doc4.xml","form_type":"4"}},{"id":2459687,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T16:40:01.000Z","date":"2021-12-21","kind":"other","acquired":false,"shares":1261,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":3726,"source":{"system":"sec-edgar","filing":"0000899243-21-049594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321049594/doc4.xml","form_type":"4"}},{"id":2459686,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T16:40:01.000Z","date":"2021-12-21","kind":"other","acquired":false,"shares":51556,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-049594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321049594/doc4.xml","form_type":"4"}},{"id":2459685,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T16:40:01.000Z","date":"2021-12-21","kind":"other","acquired":true,"shares":51556,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":51556,"source":{"system":"sec-edgar","filing":"0000899243-21-049594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321049594/doc4.xml","form_type":"4"}},{"id":2459684,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-23T16:40:01.000Z","date":"2021-12-21","kind":"other","acquired":false,"shares":200213,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. (\"Versant IV\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":614820,"source":{"system":"sec-edgar","filing":"0000899243-21-049594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321049594/doc4.xml","form_type":"4"}},{"id":2538254,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T16:38:25.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":1531,"price":15.0939,"value":23108.7609,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":4987,"source":{"system":"sec-edgar","filing":"0000899243-21-040777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321040777/doc4.xml","form_type":"4"}},{"id":2538253,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T16:38:25.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":242943,"price":15.0939,"value":3666957.3477,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":815033,"source":{"system":"sec-edgar","filing":"0000899243-21-040777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321040777/doc4.xml","form_type":"4"}},{"id":2538252,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T16:38:25.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":1912,"price":14.6327,"value":27977.7224,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $14.00 to $14.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":6518,"source":{"system":"sec-edgar","filing":"0000899243-21-040777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321040777/doc4.xml","form_type":"4"}},{"id":2538251,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-20T16:38:25.000Z","date":"2021-10-18","kind":"sale","acquired":false,"shares":303614,"price":14.6327,"value":4442692.5778,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. (\"Versant IV\") and Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $14.00 to $14.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1057976,"source":{"system":"sec-edgar","filing":"0000899243-21-040777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321040777/doc4.xml","form_type":"4"}},{"id":2712517,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T16:45:05.000Z","date":"2021-05-12","kind":"other","acquired":false,"shares":2018,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":8430,"source":{"system":"sec-edgar","filing":"0000899243-21-019515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321019515/doc4.xml","form_type":"4"}},{"id":2712516,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T16:45:05.000Z","date":"2021-05-12","kind":"other","acquired":false,"shares":82486,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-019515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321019515/doc4.xml","form_type":"4"}},{"id":2712515,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T16:45:05.000Z","date":"2021-05-12","kind":"other","acquired":true,"shares":82486,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":82486,"source":{"system":"sec-edgar","filing":"0000899243-21-019515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321019515/doc4.xml","form_type":"4"}},{"id":2712514,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T16:45:05.000Z","date":"2021-05-12","kind":"other","acquired":false,"shares":320340,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. (\"Versant IV\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1361590,"source":{"system":"sec-edgar","filing":"0000899243-21-019515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321019515/doc4.xml","form_type":"4"}},{"id":2768149,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-30T19:05:37.000Z","date":"2021-03-26","kind":"other","acquired":false,"shares":1990,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":10448,"source":{"system":"sec-edgar","filing":"0000899243-21-013968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321013968/doc4.xml","form_type":"4"}},{"id":2768148,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-30T19:05:37.000Z","date":"2021-03-26","kind":"other","acquired":false,"shares":82491,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-013968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321013968/doc4.xml","form_type":"4"}},{"id":2768147,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-30T19:05:37.000Z","date":"2021-03-26","kind":"other","acquired":true,"shares":82491,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV. William J. Link disclaims beneficial ownership of the shares held by Versant Ventures IV, except to the extent of his pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":82491,"source":{"system":"sec-edgar","filing":"0000899243-21-013968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321013968/doc4.xml","form_type":"4"}},{"id":2768146,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-30T19:05:37.000Z","date":"2021-03-26","kind":"other","acquired":false,"shares":320368,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. (\"Versant IV\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of Versant IV. William J. Link, a member of the Issuer's board of directors, is a managing member of Versant Ventures IV and may be deemed to share voting and dispositive power over the shares held by Versant IV. Each of Versant Ventures IV and William J. Link disclaims beneficial ownership of the shares held by Versant IV, except to the extent of their respective pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1681930,"source":{"system":"sec-edgar","filing":"0000899243-21-013968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321013968/doc4.xml","form_type":"4"}},{"id":2846453,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T17:16:45.000Z","date":"2021-02-17","kind":"other","acquired":false,"shares":5607,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP-GP, to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VI GP-GP. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP-GP; however, she disclaims beneficial ownership of such securities, except to the extent of her pecuniary interest therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-007412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321007412/doc4.xml","form_type":"4"}},{"id":2846452,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T17:16:45.000Z","date":"2021-02-17","kind":"other","acquired":true,"shares":5607,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of Versant Ventures VI GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures VI GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Ventures VI GP-GP. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP-GP; however, she disclaims beneficial ownership of such securities, except to the extent of her pecuniary interest therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":5607,"source":{"system":"sec-edgar","filing":"0000899243-21-007412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321007412/doc4.xml","form_type":"4"}},{"id":2846451,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T17:16:45.000Z","date":"2021-02-17","kind":"other","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures VI GP, to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the sole general partner of Versant Ventures VI GP. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP. Each of Versant Ventures VI GP-GP and Clare Ozawa disclaims beneficial ownership of the shares held by Versant Ventures VI GP, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-007412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321007412/doc4.xml","form_type":"4"}},{"id":2846450,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T17:16:45.000Z","date":"2021-02-17","kind":"other","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures VI GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant VI."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures VI GP. Versant Ventures VI GP-GP is the sole general partner of Versant Ventures VI GP. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures VI GP. Each of Versant Ventures VI GP-GP and Clare Ozawa disclaims beneficial ownership of the shares held by Versant Ventures VI GP, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0000899243-21-007412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321007412/doc4.xml","form_type":"4"}},{"id":2846449,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T17:16:45.000Z","date":"2021-02-17","kind":"other","acquired":false,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. (\"Versant VI\") to its partners pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held by Versant VI. Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the sole general partner of Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") and Versant Ventures VI GP is the sole general partner of Versant VI. Clare Ozawa, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP and Clare Ozawa disclaims beneficial ownership of the shares held by Versant VI, except to the extent of their respective pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly files separate Section 16 reports."}],"balance_after":2236888,"source":{"system":"sec-edgar","filing":"0000899243-21-007412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924321007412/doc4.xml","form_type":"4"}},{"id":2973099,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":1,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":2,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":3,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T21:18:11.000Z","date":"2020-11-17","kind":"other","acquired":false,"shares":18925,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. (\"Versant Side Fund\"), to its partners, pursuant to a Rule 10b5-1 distribution plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by Versant Side Fund. Versant Ventures IV GP is the general partner of Versant Side Fund. Kirk G. Nielsen is a managing member of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Kirk G. Nielsen is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":17040,"source":{"system":"sec-edgar","filing":"0000899243-20-031770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000089924320031770/doc4.xml","form_type":"4"}},{"id":2973098,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":1,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":2,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":3,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T21:18:11.000Z","date":"2020-11-17","kind":"other","acquired":false,"shares":164825,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV GP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV GP. Kirk G. Nielsen is a managing member of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Kirk G. Nielsen is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-031770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000089924320031770/doc4.xml","form_type":"4"}},{"id":2973097,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":1,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":2,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":3,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T21:18:11.000Z","date":"2020-11-17","kind":"other","acquired":true,"shares":164825,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures IV GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures IV GP. Kirk G. Nielsen is a managing member of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures IV GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Kirk G. Nielsen is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":164825,"source":{"system":"sec-edgar","filing":"0000899243-20-031770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000089924320031770/doc4.xml","form_type":"4"}},{"id":2973096,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":1,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":2,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":3,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T21:18:11.000Z","date":"2020-11-17","kind":"other","acquired":false,"shares":3004415,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. (\"Versant IV\"), to its partners, pursuant to a Rule 10b5-1 distribution plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant IV. Versant Ventures IV, LLC (\"Versant Ventures IV GP\") is the general partner of Versant IV. Kirk G. Nielsen is a managing member of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant IV; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Kirk G. Nielsen is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":2705162,"source":{"system":"sec-edgar","filing":"0000899243-20-031770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000089924320031770/doc4.xml","form_type":"4"}},{"id":3101880,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-23T19:22:24.000Z","date":"2020-06-19","kind":"other","acquired":false,"shares":34282,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV IV without consideration to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held by VV IV."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-038640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000120919120038640/doc4.xml","form_type":"4"}},{"id":3101879,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-23T19:22:24.000Z","date":"2020-06-19","kind":"other","acquired":true,"shares":34282,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a change in the form of ownership of VV IV  by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC IV and VSF IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held by VV IV."}],"balance_after":34282,"source":{"system":"sec-edgar","filing":"0001209191-20-038640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000120919120038640/doc4.xml","form_type":"4"}},{"id":3101878,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-23T19:22:24.000Z","date":"2020-06-19","kind":"other","acquired":false,"shares":21597,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Side Fund IV, L.P. (\"VSF IV\") without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by VSF IV.  VV IV is the sole general partner of VSF IV may be deemed to indirectly beneficially own the shares beneficially owned by VSF IV, but disclaims beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":10798,"source":{"system":"sec-edgar","filing":"0001209191-20-038640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000120919120038640/doc4.xml","form_type":"4"}},{"id":3101877,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-23T19:22:24.000Z","date":"2020-06-19","kind":"other","acquired":false,"shares":3428221,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital IV, L.P. (\"VVC IV\") without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by VVC IV.  Versant Ventures IV, LLC (\"VV IV\") is the sole general partner of VVC IV may be deemed to indirectly beneficially own the shares beneficially owned by VVC IV, but disclaims beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":1714111,"source":{"system":"sec-edgar","filing":"0001209191-20-038640","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000120919120038640/doc4.xml","form_type":"4"}},{"id":3133659,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":1,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":2,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":3,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-05-27T18:44:31.000Z","date":"2020-05-27","kind":"exercise","acquired":false,"shares":977058,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Includes (i) 970,942 shares held of record by Versant Capital and (ii) 6,116 shares held of record by Versant Side."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Versant Ventures IV, LLC (\"VV IV\") is the general partner of each of Versant Capital and Versant Side and, as a result, may be deemed to share voting and dispositive\npower over the shares held by each of Versant Capital and Versant Side and disclaims beneficial ownership of such securities except to the extent of its pecuniary\ninterest therein. Each of Brian Atwood, Bradley J. Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk G. Nielsen, Robin L. Praeger, Rebecca Robertson, Charles Warden and Tom Woiwode Ph.D., as managing members of VV IV, may be deemed to share voting and dispositive power over the shares held by Versant Capital and\nVersant Side and disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. A Form 4 is being filed separately by Mr. Nielsen in his capacity as a director of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":977058},"source":{"system":"sec-edgar","filing":"0001209191-20-032420","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000120919120032420/doc4.xml","form_type":"4"}},{"id":3133658,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":1,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":2,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":3,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-05-27T18:44:31.000Z","date":"2020-05-27","kind":"exercise","acquired":false,"shares":1197058,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Includes (i) 1,189,565 shares held of record by Versant Capital and (ii) 7,493 shares held of record by Versant Side."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Versant Ventures IV, LLC (\"VV IV\") is the general partner of each of Versant Capital and Versant Side and, as a result, may be deemed to share voting and dispositive\npower over the shares held by each of Versant Capital and Versant Side and disclaims beneficial ownership of such securities except to the extent of its pecuniary\ninterest therein. Each of Brian Atwood, Bradley J. Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk G. Nielsen, Robin L. Praeger, Rebecca Robertson, Charles Warden and Tom Woiwode Ph.D., as managing members of VV IV, may be deemed to share voting and dispositive power over the shares held by Versant Capital and\nVersant Side and disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. A Form 4 is being filed separately by Mr. Nielsen in his capacity as a director of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1197058},"source":{"system":"sec-edgar","filing":"0001209191-20-032420","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000120919120032420/doc4.xml","form_type":"4"}},{"id":3133657,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":1,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":2,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":3,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-05-27T18:44:31.000Z","date":"2020-05-27","kind":"exercise","acquired":false,"shares":3571426,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes (i) 3,549,070 shares held of record by Versant Venture Capital IV, L.P. (\"Versant Capital\") and (ii) 22,356 shares held of record by Versant Side Fund IV, L.P.\n(\"Versant Side\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Versant Ventures IV, LLC (\"VV IV\") is the general partner of each of Versant Capital and Versant Side and, as a result, may be deemed to share voting and dispositive\npower over the shares held by each of Versant Capital and Versant Side and disclaims beneficial ownership of such securities except to the extent of its pecuniary\ninterest therein. Each of Brian Atwood, Bradley J. Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk G. Nielsen, Robin L. Praeger, Rebecca Robertson, Charles Warden and Tom Woiwode Ph.D., as managing members of VV IV, may be deemed to share voting and dispositive power over the shares held by Versant Capital and\nVersant Side and disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. A Form 4 is being filed separately by Mr. Nielsen in his capacity as a director of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3571426},"source":{"system":"sec-edgar","filing":"0001209191-20-032420","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000120919120032420/doc4.xml","form_type":"4"}},{"id":3133656,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":1,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":2,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":3,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-27T18:44:31.000Z","date":"2020-05-27","kind":"exercise","acquired":true,"shares":5745542,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's common stock on a one-for-one\nbasis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes (i) 3,549,070 shares held of record by Versant Venture Capital IV, L.P. (\"Versant Capital\") and (ii) 22,356 shares held of record by Versant Side Fund IV, L.P.\n(\"Versant Side\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Includes (i) 1,189,565 shares held of record by Versant Capital and (ii) 7,493 shares held of record by Versant Side."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Includes (i) 970,942 shares held of record by Versant Capital and (ii) 6,116 shares held of record by Versant Side."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Versant Ventures IV, LLC (\"VV IV\") is the general partner of each of Versant Capital and Versant Side and, as a result, may be deemed to share voting and dispositive\npower over the shares held by each of Versant Capital and Versant Side and disclaims beneficial ownership of such securities except to the extent of its pecuniary\ninterest therein. Each of Brian Atwood, Bradley J. Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk G. Nielsen, Robin L. Praeger, Rebecca Robertson, Charles Warden and Tom Woiwode Ph.D., as managing members of VV IV, may be deemed to share voting and dispositive power over the shares held by Versant Capital and\nVersant Side and disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. A Form 4 is being filed separately by Mr. Nielsen in his capacity as a director of the Issuer."}],"balance_after":5745542,"source":{"system":"sec-edgar","filing":"0001209191-20-032420","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000120919120032420/doc4.xml","form_type":"4"}},{"id":3382254,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":566158,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Each of Bradley J. Bolzon, Jerel C. Davis, Clare Ozawa, Robin L. Praeger and Thomas F. Woiwode, as managing members of Versant Vantage I GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant Vantage; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.001 per share","underlying_shares":566158},"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382253,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":495388,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares directly held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Bradley J. Bolzon, Jerel C. Davis, Kirk G. Nielsen, Robin L. Praeger and Thomas F. Woiwode, and as November 1, 2019 Clare Ozawa, as managing members of Versant Ventures VI GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant VI; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.001 per share","underlying_shares":495388},"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382252,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":1941500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares directly held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Bradley J. Bolzon, Jerel C. Davis, Kirk G. Nielsen, Robin L. Praeger and Thomas F. Woiwode, and as November 1, 2019 Clare Ozawa, as managing members of Versant Ventures VI GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant VI; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.001 per share","underlying_shares":1941500},"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382251,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":1654359,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by  Versant Venture Capital IV, L.P. (\"Versant IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of each of Versant IV and Versant Side Fund IV. Each of Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, Kirk G. Nielsen, Thomas F. Woiwode and Robin L. Praeger, as managing members of Versant Ventures IV, may be deemed to share voting and dispositive power over the shares held by Versant IV and Versant Side Fund IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.001 per share","underlying_shares":1654359},"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382250,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":10420,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of each of Versant IV and Versant Side Fund IV. Each of Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, Kirk G. Nielsen, Thomas F. Woiwode and Robin L. Praeger, as managing members of Versant Ventures IV, may be deemed to share voting and dispositive power over the shares held by Versant IV and Versant Side Fund IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.001 per share","underlying_shares":10420},"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382249,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"purchase","acquired":true,"shares":437500,"price":16,"value":7000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Each of Bradley J. Bolzon, Jerel C. Davis, Clare Ozawa, Robin L. Praeger and Thomas F. Woiwode, as managing members of Versant Vantage I GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant Vantage; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1003658,"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382248,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":566158,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Shares held by Versant Vantage I, L.P. (\"Versant Vantage\"). Versant Vantage I GP, L.P. (\"Versant Vantage I GP\") is the general partner of Versant Vantage, and Versant Vantage I GP-GP, LLC (\"Versant Vantage I GP-GP\") is the general partner of Versant Vantage I GP. Each of Bradley J. Bolzon, Jerel C. Davis, Clare Ozawa, Robin L. Praeger and Thomas F. Woiwode, as managing members of Versant Vantage I GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant Vantage; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. Clare Ozawa is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":566158,"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382247,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"purchase","acquired":true,"shares":125000,"price":16,"value":2000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares directly held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Bradley J. Bolzon, Jerel C. Davis, Kirk G. Nielsen, Robin L. Praeger and Thomas F. Woiwode, and as November 1, 2019 Clare Ozawa, as managing members of Versant Ventures VI GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant VI; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein."}],"balance_after":2561888,"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382246,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":495388,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares directly held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Bradley J. Bolzon, Jerel C. Davis, Kirk G. Nielsen, Robin L. Praeger and Thomas F. Woiwode, and as November 1, 2019 Clare Ozawa, as managing members of Versant Ventures VI GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant VI; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein."}],"balance_after":2436888,"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382245,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":1941500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares directly held by Versant Venture Capital VI, L.P. (\"Versant VI\"). Versant Ventures VI GP, L.P. (\"Versant Ventures VI GP\") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC (\"Versant Ventures VI GP-GP\") is the general partner of Versant Ventures VI GP. Each of Bradley J. Bolzon, Jerel C. Davis, Kirk G. Nielsen, Robin L. Praeger and Thomas F. Woiwode, and as November 1, 2019 Clare Ozawa, as managing members of Versant Ventures VI GP-GP, may be deemed to share voting and dispositive power over the shares held by Versant VI; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein."}],"balance_after":1941500,"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382244,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"purchase","acquired":true,"shares":27500,"price":16,"value":440000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by  Versant Venture Capital IV, L.P. (\"Versant IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of each of Versant IV and Versant Side Fund IV. Each of Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, Kirk G. Nielsen, Thomas F. Woiwode and Robin L. Praeger, as managing members of Versant Ventures IV, may be deemed to share voting and dispositive power over the shares held by Versant IV and Versant Side Fund IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":2002298,"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382243,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":1654359,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by  Versant Venture Capital IV, L.P. (\"Versant IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of each of Versant IV and Versant Side Fund IV. Each of Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, Kirk G. Nielsen, Thomas F. Woiwode and Robin L. Praeger, as managing members of Versant Ventures IV, may be deemed to share voting and dispositive power over the shares held by Versant IV and Versant Side Fund IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":1974798,"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3382242,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":74643,"kind":"organization","name":"Versant Venture Capital VI, L.P.","position":1,"cik":"0001687880","reported_name":"Versant Venture Capital VI, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74644,"kind":"organization","name":"Versant Ventures VI GP, L.P.","position":2,"cik":"0001777654","reported_name":"Versant Ventures VI GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74645,"kind":"organization","name":"Versant Ventures VI GP-GP, LLC","position":3,"cik":"0001777652","reported_name":"Versant Ventures VI GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75031,"kind":"organization","name":"Versant Vantage I, L.P.","position":4,"cik":"0001765253","reported_name":"Versant Vantage I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75032,"kind":"organization","name":"Versant Vantage I GP, L.P.","position":5,"cik":"0001777651","reported_name":"Versant Vantage I GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75033,"kind":"organization","name":"Versant Vantage I GP-GP, LLC","position":6,"cik":"0001777653","reported_name":"Versant Vantage I GP-GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":8,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":9,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-04T17:58:31.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":10420,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, \"Preferred Stock\") automatically converted into shares of the Issuer's Common Stock (\"Shares\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant Side Fund IV, L.P. (\"Versant Side Fund IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Versant Ventures IV, LLC (\"Versant Ventures IV\") is the sole general partner of each of Versant IV and Versant Side Fund IV. Each of Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, Kirk G. Nielsen, Thomas F. Woiwode and Robin L. Praeger, as managing members of Versant Ventures IV, may be deemed to share voting and dispositive power over the shares held by Versant IV and Versant Side Fund IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein. William J. Link is a director of the Issuer and, accordingly, files separate Section 16 reports."}],"balance_after":12438,"source":{"system":"sec-edgar","filing":"0000899243-19-026602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777651/000089924319026602/doc4.xml","form_type":"4"}},{"id":3694519,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-16T14:29:08.000Z","date":"2019-01-14","kind":"other","acquired":true,"shares":817,"price":2.2984,"value":1877.7928,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 14, 2019, the Reporting Persons received an additional 130,526 shares of Ophthotech Corporation (\"Ophthotech\") common stock as a result of the post-closing adjustment as provided for in that certain Agreement and Plan of Merger dated October 30, 2018, by and among Ophthotech, Inception 4, Inc. and the other parties thereto.  No additional consideration was paid for such shares. The Reporting Persons' right to receive additional shares became fixed and irrevocable on October 30, 2018, the effective date of the merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 14, 2019, the Reporting Persons received an additional 130,526 shares of Ophthotech Corporation (\"Ophthotech\") common stock as a result of the post-closing adjustment as provided for in that certain Agreement and Plan of Merger dated October 30, 2018, by and among Ophthotech, Inception 4, Inc. and the other parties thereto.  No additional consideration was paid for such shares. The Reporting Persons' right to receive additional shares became fixed and irrevocable on October 30, 2018, the effective date of the merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This report on Form 4 is jointly filed by Versant Venture Capital IV, L.P. (\"VVC IV\") and Versant Side Fund IV, L.P. (\"VSF IV\"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such entity is a beneficial owner of such securities for the purpose of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held of record by VSF IV. VV IV is the sole general partner of VSF IV and may be deemed to have voting and investment power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley Bolzon, Ph.D., Charles M. Warden, Kirk G. Nielsen, Thomas Woiwode and Robin L. Praeger are managing directors of VV IV and share voting and dispositive power over the shares held by VSF IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein."}],"balance_after":32394,"source":{"system":"sec-edgar","filing":"0001209191-19-003905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000120919119003905/doc4.xml","form_type":"4"}},{"id":3694518,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-16T14:29:08.000Z","date":"2019-01-14","kind":"other","acquired":true,"shares":129709,"price":2.2984,"value":298123.1656,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 14, 2019, the Reporting Persons received an additional 130,526 shares of Ophthotech Corporation (\"Ophthotech\") common stock as a result of the post-closing adjustment as provided for in that certain Agreement and Plan of Merger dated October 30, 2018, by and among Ophthotech, Inception 4, Inc. and the other parties thereto.  No additional consideration was paid for such shares. The Reporting Persons' right to receive additional shares became fixed and irrevocable on October 30, 2018, the effective date of the merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 14, 2019, the Reporting Persons received an additional 130,526 shares of Ophthotech Corporation (\"Ophthotech\") common stock as a result of the post-closing adjustment as provided for in that certain Agreement and Plan of Merger dated October 30, 2018, by and among Ophthotech, Inception 4, Inc. and the other parties thereto.  No additional consideration was paid for such shares. The Reporting Persons' right to receive additional shares became fixed and irrevocable on October 30, 2018, the effective date of the merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This report on Form 4 is jointly filed by Versant Venture Capital IV, L.P. (\"VVC IV\") and Versant Side Fund IV, L.P. (\"VSF IV\"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such entity is a beneficial owner of such securities for the purpose of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held of record by VVC IV. Versant Ventures IV, LLC (\"VV IV\") is the sole general partner of VVC IV and may be deemed to have voting and investment power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Rebecca B. Robertson, Bradley Bolzon, Ph.D., Charles M. Warden, Kirk G. Nielsen, Thomas Woiwode and Robin L. Praeger are managing directors of VV IV and share voting and dispositive power over the shares held by VVC IV; however, they each disclaim beneficial ownership of such securities, except to the extent of their pecuniary interests therein."}],"balance_after":5142333,"source":{"system":"sec-edgar","filing":"0001209191-19-003905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1456589/000120919119003905/doc4.xml","form_type":"4"}},{"id":3958063,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":4,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":5,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":6,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-04-24T23:44:23.000Z","date":"2018-04-23","kind":"sale","acquired":false,"shares":6821,"price":50.66,"value":345551.86,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F15","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Versant Venture Capital V (Canada), L.P.\n(\"VVC CAN\")."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $54.00 per share, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"These securities are held of record by VVC CAN. Versant Ventures V GP-GP (Canada), Inc. (\"VV V CAN GP\") is the sole general partner of Versant Ventures V (Canada), L.P. (\"VV V CAN\") and VV V CAN is the sole general partner of VVC CAN. VV V CAN GP and VV V CAN may be deemed to have voting and investment power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities, however, VV V CAN GP and VV V CAN each disclaim beneficial ownership of the securities held by VVC CAN, except to the extent of their pecuniary interests therein."}],"balance_after":117173,"source":{"system":"sec-edgar","filing":"0000899243-18-010684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318010684/doc4.xml","form_type":"4"}},{"id":3958062,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":4,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":5,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":6,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-04-24T23:44:23.000Z","date":"2018-04-23","kind":"sale","acquired":false,"shares":2915,"price":51,"value":148665.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Versant Ophthalmic Affiliates Fund I, L.P.  (\"VOA\")."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $54.00 per share, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"These securities are held of record by VOA. VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VOA, except to the extent of its pecuniary interest therein."}],"balance_after":50072,"source":{"system":"sec-edgar","filing":"0000899243-18-010684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318010684/doc4.xml","form_type":"4"}},{"id":3958061,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":4,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":5,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":6,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-04-24T23:44:23.000Z","date":"2018-04-23","kind":"sale","acquired":false,"shares":2630,"price":51,"value":134130.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Versant Affiliates Fund V, L.P. (\"VAF V\")."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $54.00 per share, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"These securities are held of record by VAF V. VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VAF V, except to the extent of its pecuniary interest therein."}],"balance_after":45171,"source":{"system":"sec-edgar","filing":"0000899243-18-010684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318010684/doc4.xml","form_type":"4"}},{"id":3958060,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":4,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":5,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":6,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-04-24T23:44:23.000Z","date":"2018-04-23","kind":"sale","acquired":false,"shares":89628,"price":50.66,"value":4540554.48,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Versant Venture Capital V, L.P. (\"VVC V\")."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $54.00 per share, inclusive. The reporting person undertakes to provide to CRISPR Therapeutics AG, any security holder of CRISPR Therapeutics AG, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"These securities are held of record by VVC V. Versant Ventures V, LLC (\"VV V\") is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VVC V, except to the extent of its pecuniary interest therein."}],"balance_after":1539576,"source":{"system":"sec-edgar","filing":"0000899243-18-010684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318010684/doc4.xml","form_type":"4"}},{"id":3958059,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":4,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":5,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":6,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-04-24T23:44:23.000Z","date":"2018-04-20","kind":"other","acquired":false,"shares":92918,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV IV without consideration to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held by VV IV."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-010684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318010684/doc4.xml","form_type":"4"}},{"id":3958058,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":4,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":5,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":6,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-04-24T23:44:23.000Z","date":"2018-04-20","kind":"other","acquired":true,"shares":92918,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a change in the form of ownership of VV IV by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC IV and VSF IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held by VV IV."}],"balance_after":92918,"source":{"system":"sec-edgar","filing":"0000899243-18-010684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318010684/doc4.xml","form_type":"4"}},{"id":3958057,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":4,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":5,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":6,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-04-24T23:44:23.000Z","date":"2018-04-20","kind":"other","acquired":false,"shares":2947,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Side Fund IV, L.P. (\"VSF IV\") without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held of record by VSF IV. VV IV is the sole general partner of VSF IV and may be deemed to have voting and investment power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":13277,"source":{"system":"sec-edgar","filing":"0000899243-18-010684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318010684/doc4.xml","form_type":"4"}},{"id":3958056,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":3,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":4,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":5,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":6,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":7,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2018-04-24T23:44:23.000Z","date":"2018-04-20","kind":"other","acquired":false,"shares":497053,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital IV, L.P. (\"VVC IV\") without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by VVC IV. Versant Ventures IV, LLC (\"VV IV\") is the sole general partner of VVC IV and may be deemed to have voting and investment power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":2238979,"source":{"system":"sec-edgar","filing":"0000899243-18-010684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000089924318010684/doc4.xml","form_type":"4"}},{"id":4214860,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":false,"shares":1240,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F21","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV V CAN without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F20","text":"The shares are held VV V CAN."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214859,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":true,"shares":1240,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F19","text":"Represents a change in the form of ownership of VV V CAN by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC CAN."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F20","text":"The shares are held VV V CAN."}],"balance_after":1240,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214858,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":false,"shares":17283,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F18","text":".  Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV V without consideration to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F17","text":"The shares are held VV V."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214857,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":true,"shares":17283,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F16","text":"Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC V, VAF V and VOA."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F17","text":"The shares are held VV V."}],"balance_after":17283,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214856,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":false,"shares":292529,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F15","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by VV IV without consideration to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The shares are held VV IV."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214855,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":true,"shares":292529,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F13","text":"Represents a change in the form of ownership of VV IV by virtue of the receipt of shares in the pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by VVC IV and VSF IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"The shares are held VV IV."}],"balance_after":292529,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214854,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":false,"shares":26491,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Ophthalmic Affiliates Fund I, L.P. (\"VOA\") without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"These securities are held of record by VOA. VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VOA, except to the extent of its pecuniary interest therein."}],"balance_after":52987,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214853,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":false,"shares":61993,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital V (Canada) LP (\"VVC CAN\") without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"These securities are held of record by VVC CAN. Versant Ventures V GP-GP (Canada), Inc. (\"VV V CAN GP\") is the sole general partner of Versant Ventures V (Canada), L.P. (\"VV V CAN\") and VV V CAN is the sole general partner of VVC CAN. VV V CAN GP and VV V CAN may be deemed to have voting and investment power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities, however, each disclaim beneficial ownership of the securities held by VVC CAN, except to the extent of their respective pecuniary interests therein."}],"balance_after":123994,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214852,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":false,"shares":23899,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Affiliates Fund V, L.P. (\"VAF V\") without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These securities are held of record by VAF V.  VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VAF V, except to the extent of its pecuniary interest therein."}],"balance_after":47801,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214851,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":false,"shares":814599,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital V, L.P. (\"VVC V\") without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are held of record by VVC V. Versant Ventures V, LLC (\"VV V\") is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VVC V, except to the extent of its pecuniary interest therein."}],"balance_after":1629204,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214850,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":false,"shares":8110,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Side Fund IV, L.P. (\"VSF IV\") without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held of record by VSF IV. VV IV is the sole general partner of VSF IV and may be deemed to have voting and investment power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VSF IV, except to the extent of its pecuniary interest therein."}],"balance_after":16224,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4214849,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88365,"kind":"organization","name":"Versant Ventures IV, LLC","position":7,"cik":"0001456589","reported_name":"Versant Ventures IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76647,"kind":"organization","name":"Versant Ventures V, LLC","position":8,"cik":"0001619298","reported_name":"Versant Ventures V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76652,"kind":"organization","name":"Versant Ventures V (Canada), L.P.","position":9,"cik":"0001716490","reported_name":"Versant Ventures V (Canada), L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T21:35:17.000Z","date":"2017-09-05","kind":"other","acquired":false,"shares":1368013,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"see footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital IV, L.P. (\"VVC IV\") without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held of record by VVC IV. Versant Ventures IV, LLC (\"VV IV\") is the sole general partner of VVC IV and may be deemed to have voting and investment power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VVC IV, except to the extent of its pecuniary interest therein."}],"balance_after":2736032,"source":{"system":"sec-edgar","filing":"0001209191-17-051986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716490/000120919117051986/doc4.xml","form_type":"4"}},{"id":4512550,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":88366,"kind":"organization","name":"Versant Venture Capital IV, L.P.","position":1,"cik":"0001456590","reported_name":"Versant Venture Capital IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":88367,"kind":"organization","name":"Versant Side Fund IV, L.P.","position":2,"cik":"0001456591","reported_name":"Versant Side Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76648,"kind":"organization","name":"Versant Venture Capital V, L.P.","position":3,"cik":"0001589097","reported_name":"Versant Venture Capital V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76650,"kind":"organization","name":"Versant Affiliates Fund V, L.P.","position":4,"cik":"0001589095","reported_name":"Versant Affiliates Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76649,"kind":"organization","name":"Versant Ophthalmic Affiliates I, L.P.","position":5,"cik":"0001589098","reported_name":"Versant Ophthalmic Affiliates I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":76653,"kind":"organization","name":"Versant Venture Capital V (Canada), LP","position":6,"cik":"0001612235","reported_name":"Versant Venture Capital V (Canada), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Shares","published_at":"2016-12-23T23:03:40.000Z","date":"2016-10-24","kind":"exercise","acquired":false,"shares":5774,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series A-3 Preferred Stock and Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock in its firm commitment initial public offering pursuant to the Issuer's prospectus (Form 424B4) filed with the Securities and Exchange Commission on October 19, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series A-3 Preferred Stock and Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock in its firm commitment initial public offering pursuant to the Issuer's prospectus (Form 424B4) filed with the Securities and Exchange Commission on October 19, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series A-3 Preferred Stock and Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock in its firm commitment initial public offering pursuant to the Issuer's prospectus (Form 424B4) filed with the Securities and Exchange Commission on October 19, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series A-3 Preferred Stock and Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock in its firm commitment initial public offering pursuant to the Issuer's prospectus (Form 424B4) filed with the Securities and Exchange Commission on October 19, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These securities are held of record by Versant Ophthalmic Affiliates Fund I, L.P. (\"VOA\"). VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VOA, except to the extent of its pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5774},"source":{"system":"sec-edgar","filing":"0001104659-16-163806","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":32,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000110465916163806/a4a.xml","form_type":"4/A","original_submission_date":"2016-10-26"}}],"next_cursor":"2016-12-23T23:03:40.000000Z,4512550"}